Health Insurance Design and Conservative Therapy for Low Back Pain

This study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.

ABSTRACT

Objectives: To determine the association of health insurance benefit design features with choice of early conservative therapy for patients with new-onset low back pain (LBP).

Study Design: Observational study of 117,448 commercially insured adults 18 years or older presenting with an outpatient diagnosis of new-onset LBP between 2008 and 2013 as recorded in the OptumLabs Data Warehouse.

Methods: We identified patients who chose a primary care physician (PCP), physical therapist, or chiropractor as their entry-point provider. The main analyses were logistic regression models that estimated the likelihood of choosing a physical therapist versus a PCP and choosing a chiropractor versus a PCP. Key independent variables were health plan type, co-payment, deductible, and participation in a health reimbursement account (HRA) or health savings account (HSA). Models controlled for patient demographic and clinical characteristics.

Results: Selection of entry-point provider was moderately responsive to the incentives that patients faced. Those covered under plan types with greater restrictions on provider choice were less likely to choose conservative therapy compared with those covered under the least restrictive plan type. Results also indicated a general pattern of higher likelihood of treatment with physical therapy at lower levels of patient cost sharing. We did not observe consistent associations between participation in HRAs or HSAs and choice of conservative therapy.

Conclusions: Modification of health insurance benefit designs offers an opportunity for creating greater value in treatment of new-onset LBP by encouraging patients to choose noninvasive conservative management that will result in long-term economic and social benefits.

Am J Manag Care. 2019;25(6):e182-e187View an infographic of this abstract here.Takeaway Points

Current guidelines for management of low back pain recommend early conservative treatment, such as physical therapy or chiropractic care, but patient choice of first-line treatment may be influenced by health insurance features. We examined the choice of a physical therapist or a chiropractor compared with a primary care physician as the entry-point provider for a large sample of commercially insured adults who received diagnoses of new-onset low back pain.

  • Patients covered under plan types with greater restrictions on provider choice were less likely to choose conservative therapy.
  • Higher patient out-of-pocket cost was associated with lower likelihood of choosing conservative therapy.

Low back pain (LBP) is among the most common medical conditions in the United States, with 70% of people experiencing symptoms at least once in their lifetime.1-3 The high prevalence of LBP translates into high healthcare costs for treatment, as well as considerable indirect costs associated with lost productivity.4,5 Current guidelines for treating LBP recommend noninvasive conservative management and avoiding more

aggressive and costlier options during earlier stages of care.6-8

Prior studies have found that patterns of care, including initial provider and timing of treatment, affect the cost of medical care for LBP. Patients with new-onset LBP who were referred to a physical therapist within 3 days9 or 4 weeks10 of onset had lower LBP-related healthcare utilization and costs during the following year. A similar study found lower follow-up costs over a 2-year period.11 Chiropractic care also was relatively cost-effective for treatment of chronic LBP.12-14 However, evidence is inconsistent. Results of a randomized clinical trial indicate that compared with referral to physical therapy from a primary care physician (PCP) after several weeks of persistent LBP, early utilization of physical therapy was associated with increased costs.15 A study of care management of LBP in a managed care organization found chiropractic management to be less costly than medical management when care extended beyond primary care but not when compared with primary care alone.16

Despite the availability of clinical practice guidelines for treating LBP, the current US healthcare system often fails to successfully engage patients and their providers in adherence to those guidelines.17 The relative value of different treatment options may be realized only over the course of an extended episode of illness and often is not aligned with patient cost-sharing policies imposed by payers. At the point of new symptom onset, patient preference for provider type may be strongly influenced by out-of-pocket (OOP) costs, which may be higher for patients who choose conservative therapy that involves repeated visits to a physical therapist or chiropractor. Hence, it is possible that financial barriers deter patients from seeking early conservative therapy despite its high value relative to other available treatment options.8

Health insurers offer a range of benefit designs with embedded financial incentives affecting patient choice.18 One feature is limitations on access to providers. Health maintenance organizations (HMOs) and exclusive provider organizations (EPOs) are the most restrictive plan types, providing coverage only for providers included in network. HMOs and EPOs also require a designated PCP for each enrollee and PCP referrals to specialists. Preferred provider organizations (PPOs) are the least restrictive, generally offering a wide range of providers, with out-of-network coverage subject to higher cost sharing. Point of service (POS) plans are hybrid plans offering varying blends of HMO and PPO plan characteristics. We hypothesized that lower restrictions on provider access would be associated with higher likelihood of choosing conservative therapy for new-onset LBP.

Financial incentives also are present in patient OOP cost sharing at the point of service. Most health insurance plans have a deductible, which requires that a patient pay a fixed amount per calendar year before plan payment begins. Depending on the amount of the deductible and the amount already used at the time of a new episode of care, the deductible can require high patient OOP cost, strongly influencing patient choice of provider. A patient who does not expect to exhaust the deductible during the period of coverage faces full cost at the point of service and may be disinclined to choose conservative therapy involving multiple visits to a physical therapist or chiropractor.

Patient OOP costs also are affected by co-payments, which are fixed amounts charged to the patient, and/or by coinsurance, which varies as a percentage of the overall payment. Co-payments and coinsurance vary across health plans, and in the case of co-payments, there may be variation within plans across provider types. Relatively high co-payments or coinsurance for visits to physical therapy or chiropractic care present disincentives for patients with new-onset LBP to seek early conservative therapy, particularly if patients anticipate a number of visits requiring repeated charges.

The strongest financial incentives facing patients are encompassed in the growing system of consumer-driven healthcare, which couples high-deductible health plans with health reimbursement accounts (HRAs) or health savings accounts (HSAs).19 Premiums on these plans cost less, but the patient pays the full cost of care up to the level of the deductible using a prefunded spending account subsidized by employer contributions and/or consumer savings. The rationale behind consumer-driven healthcare is to provide patients with incentives to make high-value decisions about the healthcare they receive by managing their own healthcare budgets. Consumer-driven healthcare is a relatively new form of health insurance and evidence is mixed; however, although high-deductible health plans are associated with lower costs, this comes from reduction in inappropriate services but also in reduced utilization of appropriate preventive care and medication adherence.20

In order to better understand the impact of health insurance benefit design on provider choice, we examined the relationship between common features of commercial health insurance plans and patient selection of PCP versus physical therapist or chiropractor as first-line provider for new-onset LBP.

METHODS

Study Population

We studied commercially insured adults 18 years or older with an outpatient diagnosis of new-onset LBP during 2008-2013 as recorded in claims from the OptumLabs Data Warehouse.21 (See eAppendix A [eAppendices available at ajmc.com].) Inclusion criteria required 24 months of continuous enrollment before and following the index event with no prior diagnosis of LBP or back procedures, including spinal surgery, spinal injections, or spinal cord stimulators, and no filled opioid prescriptions during the 12 months prior to the index event. Also excluded were those with any neoplasm diagnosis in the 12 months prior to and 3 months on or following the index date and, additionally, in the 3 months on or following that date, LBP-related diagnoses that would typically not be amenable to conservative therapy (ie, spinal fractures, vertebral dislocations, inflammatory spondyloarthropathies, intraspinal abscess).

Based on the index LBP date, we selected 117,448 patients whose entry-point providers were characterized as a physical therapist, chiropractor, or PCP and for whom benefit design information was available. (The benefit design criteria excluded Medicare Advantage enrollees.) PCPs included family medicine practitioners, pediatricians, internists, obstetricians, gynecologists, hospitalists, and geriatricians. We focused on 2 samples: (1) 82,052 patients whose first encounter was with either a PCP or a physical therapist and (2) 115,144 patients whose first encounter was with either a PCP or a chiropractor (see eAppendix B).

Descriptive Analysis

Descriptive statistics were reported as counts and proportions for categorical variables representing plan type (POS, EPO, HMO, PPO), co-payment, deductible, and consumer-driven health plan (CDHP) by sample. We included the number and percent of patients whose entry-point provider was a physical therapist or a chiropractor overall and by category within each benefit design feature. We omitted analysis of coinsurance; more than 95% of patients had no coinsurance for 90 days following the index date, with little variation among patients who did.

Statistical Analysis

Our main analyses consisted of 2 sets of multivariable logistic regressions. The dependent variable in the first set was physical therapist versus PCP as entry-point provider. We estimated 4 logistic regressions with this dependent variable, 1 for each benefit design feature: plan type, co-payment, deductible, and CDHP. The key independent variables were categorical variables measuring the benefit design feature, and reference groups were POS plan type, zero co-payment, zero deductible, and neither type of CDHP. The second set of 4 logistic regressions was structured similarly, with the dependent variable being choice of chiropractor versus PCP as entry-point provider. For all logistic models, we calculated adjusted odds ratios with 95% Wald CIs. We also evaluated overall model fit, model discrimination (C statistic), and calibration (Hosmer—Lemeshow test) for all logistic models (see eAppendix C).

Although our main interest was in the association of benefit design features with the likelihood of patients choosing a physical therapist or a chiropractor as entry-point provider, all regression models included a broad range of covariates. Patient demographic characteristics included age, gender, race/ethnicity, and US region. (Race and ethnicity are based on imputation and are not separately defined in the OptumLabs Data Warehouse.21 The specified categories are black, Hispanic, Asian, and white.) We included a modified Elixhauser index (in which mental health conditions were excluded) to account for physical comorbidities, treated as a continuous variable.22 We also included 9 binary variables to control for individual mental health comorbidities, 8 selected from the CMS list of chronic health conditions23 and a single condition representing fibromyalgia, chronic pain, and fatigue. For the physical therapy regressions, we also included a categorical variable that measured the level of direct access to physical therapy afforded to insured patients according to various state regulations, as categorized by the American Physical Therapy Association: limited, provisional, or unrestricted.24 Other covariates are listed in eAppendix D Tables 1 to 8.

RESULTS

In the Table, we present descriptive data on the distribution of benefit features and choice of entry-point provider for the 117,448 patients included in the analyses. Of the 82,052 patients in the PCP versus physical therapist sample, 2.8% chose the latter provider. POS was the dominant plan type, followed by EPO, PPO, and HMO. Approximately 31% of patients in this sample had zero co-payments and 23% had zero deductibles. Patients in CDHPs made up only about 20% of the total. Regression results for all logistic models are contained in eAppendix D Tables 1 to 8.

Choice of conservative therapy was higher for the 115,144 patients in the chiropractor versus PCP sample; 31% of patients chose a chiropractor as their entry-point provider. The distribution among plans differed little, with the largest portion also enrolled in a POS plan, followed by EPO, PPO, and HMO plans. The percentages of patients with zero co-payments, zero deductibles, or CDHP participation were similar to those in the previous sample.

Physical Therapy

Figure 1 depicts odds ratios generated from results of the physical therapy logistic regressions. Among plan types, PPO plans were associated with the highest odds of seeing a physical therapist first; PPO patients had a 32% higher likelihood of seeing a physical therapist than a patient enrolled in a POS plan. EPO plans were associated with the lowest odds; these patients were 16% less likely than POS patients to see a physical therapist first.

The odds of seeing a physical therapist as first provider decline steadily as co-payment increases. Those in the highest category, patients with a co-payment of greater than $30, were 29% less likely to see a physical therapist first than patients whose co-payment was zero. The association of physical therapist first with OOP costs is also observed with deductibles, for which we observe a general decline in the odds of seeing a physical therapist first as the deductible increases. In the deductible range of $1001 to $1500, the odds are 19% lower than for zero deductible, and for deductibles greater than $1500, the odds are 11% lower. The regressions that included CDHPs produced mixed results. Patients with HRAs are 16% less likely to see a physical therapist first compared with patients without CDHPs; however, those with HSAs are 25% more likely.

Chiropractic Care

We present odds ratios obtained from the results of the logistic regressions in which the outcome variable was chiropractor versus PCP in Figure 2. With regard to plan design, there are some similarities to the physical therapist regression results. Patients in PPO plans had the highest likelihood of seeing a chiropractor first; the odds were 21% higher than for those in POS plans. As was the case for the analysis of physical therapists versus PCPs, EPO patients are less likely to choose chiropractors; the odds were 14% lower than for POS patients. However, unlike the analyses for physical therapists versus PCPs, HMO patients also were less likely to choose chiropractors; the odds ratio is the lowest, indicating a 28% lower likelihood of choosing such providers.

Results reveal little association between co-payments and choice of chiropractor first. Relative to $0 co-payment, the odds were only slightly lower for the categories of $1 to $20 and $21 to $30 and were not different for the highest co-payment category (>$30). Except for the highest category of deductibles (>$1500), other categories, relative to a $0 deductible, actually showed a slightly higher likelihood of seeing a chiropractor. Patients with a deductible of greater than $1500 were 7% less likely to choose a chiropractor as entry-point provider. With regard to CDHPs, those with HRAs, in comparison with those without CDHPs, had slightly higher odds of seeing a chiropractor, whereas there was no significant association for HSAs.

DISCUSSION

The study involves a retrospective analysis of claims data from the OptumLabs Data Warehouse,21 which includes deidentified claims data for privately insured and Medicare Advantage enrollees in a large, private US health plan. The database contains longitudinal health information on enrollees, representing a diverse mix of ages, ethnicities, and geographical regions across the United States. The health plan provides comprehensive full insurance coverage for physician, hospital, and prescription drug services. Overall, findings demonstrate that patients’ selection of entry-point provider was responsive to the incentives that they faced. Patients covered under health plans with the most restrictions on provider choice were less likely to choose a physical therapist or chiropractor over a PCP, and those under the least restrictive plan type were more likely. We also observed a pattern indicating that the likelihood of choosing a physical therapist declined as patient OOP cost increased. This result was less evident for choice of chiropractor. Results exploring the relationship between choice of conservative therapy and participation in a CDHP were largely inconclusive.

CDHP designs couple high-deductible plans with health spending accounts and have become increasingly prevalent since the 2000s. The rationale is that requiring patients to shoulder a greater share of the cost of their care will encourage them to reduce unnecessary utilization. However, studies have shown that reductions in spending are not necessarily accompanied by improvement in value, particularly if patients bypass routine care that would prevent higher downstream costs.20,25 Patients who were enrolled in HRAs were somewhat less likely to choose physical therapy, but those enrolled in HSAs were more likely. It may be that incentives placed by HRAs, which are accounts funded by employer contributions, differ from those placed by HSAs, which are funded by both consumers’ personal savings and employer contributions. Consumer sensitivity to the cost of care may be higher when their personal contributions are at stake. Affordability may also play a role, as individuals in HSAs may have higher available income compared with individuals in HRAs.26 Future studies that explore these possibilities would be a useful direction for research on consumer-driven healthcare.

In designing insurance products, managed care organizations make use of various financial incentives and management strategies aimed at controlling expenditures. These range from supply-side controls that place restrictions on utilization to looser demand-side approaches that affect patient OOP costs. Of late, under pressure to reduce growing healthcare expenditures, health insurers and employers have been increasing the level of patient cost sharing at the point of service, elevating the role of benefit design in shaping patient preferences. This development is part of a larger movement toward redesigning benefits in order to encourage patient decision making that aligns the prices of medical services with the value of those services.27,28 Value-based insurance design is based on the notion that the value of a treatment to a patient depends not only on the perceived therapeutic effect but also on the price of the treatment relative to other options.18 In this scenario, a patient with new-onset LBP covered under a health plan with a relatively low or zero OOP cost for physical therapy or chiropractic care may be more likely to choose early conservative therapy, in harmony with the clinical guidelines.

In addition to the economic value of potentially avoided downstream costs, policies that encourage patients with LBP to choose early conservative therapy may have a particular social advantage. Mounting evidence suggests that initial conservative treatment of LBP by a physical therapist, chiropractor, or acupuncturist decreases the odds of early and long-term opioid use.11,29,30 Hence, we postulate that benefit redesign that is successful in realizing initial conservative treatment for LBP may also indirectly have a positive bearing on restraining the growing problem of overprescribed opioids.

Limitations

This study analyzed only patients who sought medical care for LBP and whose entry-point provider was either a physical therapist, a chiropractor, or a PCP. We did not consider patients who chose other providers for first-line treatment, and we had no information on severity of the patients’ pain, their incomes, or other sociodemographic information that might affect provider choice. Although selection effects of providers cannot be ruled out, we attempted to mitigate the risk of observed effects being driven by selection through stringent exclusionary criteria. Still, the conclusions drawn are associations between benefit design and first provider, and they do not demonstrate a causal connection.

Finally, we examined benefit design features individually, but there may be complex interactions among features that could confound our results. A useful future research direction aimed toward improving the value embedded in health insurance plans would be to investigate the joint impact of various features of benefit designs.

CONCLUSIONS

Evidence-based guidelines for treatment of LBP recommend early conservative therapy with referral to other providers for patients who do not improve within a few weeks.31 Yet many patients experiencing a new episode of LBP turn to other nonconservative, first-line treatments that may involve greater cost and/or advanced testing and medications such as opioids. Our study has demonstrated that patients experiencing LBP are moderately responsive to network restrictions and cost sharing in their choice of entry-point provider. This suggests that innovative modifications to insurance benefits offer an opportunity for increased alignment with clinical practice guidelines and greater value. To date, incentive-based insurance benefit design has been applied mainly to prescription drug pricing through mechanisms such as tiered formularies and, more recently, through the Affordable Care Act, requirement of zero cost sharing for preventive services covered by insurance sold on the exchanges.18,32 Moving forward, benefit managers and regulators need to advance such principles more broadly by developing new designs and policies aimed at encouraging behaviors that will result in the largest long-term economic and social benefits.Author Affiliations: Department of Health Law, Policy, and Management (KC, OA, BG, JR, MS, RS, LK), and Department of Biostatistics (HC), Boston University School of Public Health, Boston, MA; OptumLabs (OA), Cambridge, MA; University of Pittsburgh School of Health and Rehabilitation Sciences (CM), Pittsburgh, PA; Department of Family Medicine, Boston Medical Center (RS), Boston, MA.

Source of Funding: This project was supported by United Healthcare, OptumLabs, and the American Physical Therapy Association.

Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Authorship Information: Concept and design (KC, OA, JR, CM, RS, LK); acquisition of data (OA, LK); analysis and interpretation of data (KC, OA, BG, JR, HC, CM, MS, RS, LK); drafting of the manuscript (KC, OA, HC, MS, RS); critical revision of the manuscript for important intellectual content (KC, OA, BG, JR, HC, CM, MS, RS, LK); statistical analysis (OA, HC); obtaining funding (RS, LK); administrative, technical, or logistic support (BG, LK); and supervision (LK).

Address Correspondence to: Kathleen Carey, PhD, Department of Health Law, Policy, and Management, Boston University School of Public Health, 715 Albany St, Boston, MA 02118. Email: kcarey@bu.edu.REFERENCES

1. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009;22(1):62-68. doi: 10.3122/jabfm.2009.01.080102.

2. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10. 2014;(260):1-161.

3. Shmagel A, Krebs E, Ensrud K, Foley R. Illicit substance use in US adults with chronic low back pain. Spine (Phila Pa 1976). 2016;41(17):1372-1377. doi: 10.1097/BRS.0000000000001702.

4. Davis MA, Onega T, Weeks WB, Lurie JD. Where the United States spends its spine dollars: expenditures on different ambulatory services for the management of back and neck conditions. Spine (Phila Pa 1976). 2012;37(19):1693-1701. doi: 10.1097/BRS.0b013e3182541f45.

5. Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil. 2014;95(5):986-995.e1. doi: 10.1016/j.apmr.2013.10.032.

6. Williams CM, Maher CG, Hancock MJ, et al. Low back pain and best practice care: a survey of general practice physicians. Arch Intern Med. 2010;170(3):271-277. doi: 10.1001/archinternmed.2009.507.

7. Chou R, Deyo R, Friedly J, et al. Noninvasive Treatments for Low Back Pain. Rockville, MD: Agency for Healthcare Research and Quality; 2016.

8. Maeng DD, Graboski A, Allison PL, Fisher DY, Bulger JB. Impact of a value-based insurance design for physical therapy to treat back pain on care utilization and cost. J Pain Res. 2017;10:1337-1346. doi: 10.2147/JPR.S135813.

9. Liu X, Hanney WJ, Masaracchio M, et al. Immediate physical therapy initiation in patients with acute low back pain is associated with a reduction in downstream health care utilization and costs. Phys Ther. 2018;98(5):336-347. doi: 10.1093/ptj/pzy023.

10. Gellhorn AC, Chan L, Martin B, Friedly J. Management patterns in acute low back pain: the role of physical therapy. Spine (Phila Pa 1976). 2012;37(9):775-782. doi: 10.1097/BRS.0b013e3181d79a09.

11. Childs JD, Fritz JM, Wu SS, et al. Implications of early and guideline adherent physical therapy for low back pain on utilization and costs [erratum in BMC Health Serv Res. 2016;16(1):444. doi: 10.1186/s12913-016-1681-2]. BMC Health Serv Res. 2015;15:150. doi: 10.1186/s12913-015-0830-3.

12. Haas M, Sharma R, Stano M. Cost-effectiveness of medical and chiropractic care for acute and chronic low back pain. J Manipulative Physiol Ther. 2005;28(8):555-563. doi: 10.1016/j.jmpt.2005.08.006.

13. Tsertsvadze A, Clar C, Court R, Clarke A, Mistry H, Sutcliffe P. Cost-effectiveness of manual therapy for the management of musculoskeletal conditions: a systematic review and narrative synthesis of evidence from randomized controlled trials. J Manipulative Physiol Ther. 2014;37(6):343-362. doi: 10.1016/j.jmpt.2014.05.001.

14. Liliedahl RL, Finch MD, Axene DV, Goertz CM. Cost of care for common back pain conditions initiated with chiropractic doctor vs medical doctor/doctor of osteopathy as first physician: experience of one Tennessee-based general health insurer. J Manipulative Physiol Ther. 2010;33(9):640-643. doi: 10.1016/j.jmpt.2010.08.018.

15. Fritz JM, Magel JS, McFadden M, et al. Early physical therapy vs usual care in patients with recent-onset low back pain: a randomized clinical trial. JAMA. 2015;314(14):1459-1467. doi: 10.1001/jama.2015.11648.

16. Grieves B, Menke JM, Pursel KJ. Cost minimization analysis of low back pain claims data for chiropractic vs medicine in a managed care organization [erratum in J Manipulative Physiol Ther. 2010;33(2):164]. J Manipulative Physiol Ther. 2009;32(9):734-739. doi: 10.1016/j.jmpt.2009.10.001.

17. Fritz JM. Physical therapy in a value-based healthcare world. J Orthop Sports Phys Ther. 2012;42(1):1-2. doi: 10.2519/jospt.2012.0101.

18. Ogbechie OA, Hsu J. Systematic review of benefit designs with differential cost sharing for prescription drugs. Am J Manag Care. 2015;21(5):e338-e348.

19. Robinson JC, Ginsburg PB. Consumer-driven health care: promise and performance. Health Aff (Millwood). 2009;28(2):w272-w281. doi: 10.1377/hlthaff.28.2.w272.

20. Agarwal R, Mazurenko O, Menachemi N. High-deductible health plans reduce health care cost and utilization, including use of needed preventive services. Health Aff (Millwood). 2017;36(10):1762-1768. doi: 10.1377/hlthaff.2017.0610.

21. OptumLabs. OptumLabs and OptumLabs Data Warehouse (OLDW) descriptions and citation. Cambridge, MA: n.p., February 2018. PDF. Reproduced with permission from OptumLabs.

22. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.

23. Condition categories. Chronic Conditions Data Warehouse website. ccwdata.org/web/guest/condition-categories. Accessed January 23, 2018.

24. Levels of patient access to physical therapist services in the states. American Physical Therapy Association website. apta.org/uploadedFiles/APTAorg/Advocacy/State/Issues/Direct_Access/DirectAccessbyState.pdf. Published June 20, 2016. Accessed March 19, 2018.

25. Fronstin P, Sepúlveda MJ, Roebuck MC. Consumer-directed health plans reduce the long-term use of outpatient physician visits and prescription drugs. Health Aff (Millwood). 2013;32(6):1126-1134. doi: 10.1377/hlthaff.2012.0493.

26. Helmchen LA, Brown DW, Lurie IZ, Lo Sasso AT. Health savings accounts: growth concentrated among high-income households and large employers. Health Aff (Millwood). 2015;34(9):1594-1598. doi: 10.1377/hlthaff.2015.0480.

27. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26(2):w195-w203. doi: 10.1377/hlthaff.26.2.w195.

28. Fendrick AM, Chernew ME. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am J Manag Care. 2006;12(spec):SP5-SP10.

29. Whedon JM, Toler AWJ, Goehl JM, Kazal LA. Association between utilization of chiropractic services for treatment of low-back pain and use of prescription opioids. J Altern Complement Med. 2018;24(6):552-556. doi: 10.1089/acm.2017.0131.

30. Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM. Physical therapy as the first point of care to treat low back pain: an instrumental variables approach to estimate impact on opioid prescription, health care utilization, and costs. Health Serv Res. 2018;53(6):4629-4646. doi: 10.1111/1475-6773.12984.

31. Fritz JM, Kim M, Magel JS, Asche CV. Cost-effectiveness of primary care management with or without early physical therapy for acute low back pain. Spine (Phila Pa 1976). 2017;42(5):285-290. doi: 10.1097/BRS.0000000000001729.

32. Wallace J, Sommers BD. Health insurance effects on preventive care and health: a methodologic review. Am J Prev Med. 2016;50(5 suppl 1):S27-S33. doi: 10.1016/j.amepre.2016.01.003.